Joseph Payne, Arcturus CEO (Arcturus via YouTube)
Arcturus touts $63M BARDA award for new mRNA influenza vaccine, hoping to prep against future pandemics
A San Diego mRNA biotech is looking to expand its efforts in influenza, and a federal award will bring it closer to that goal. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
